TW200603793A - Oral sustained release formulation of tedisamil with gastric retention properties - Google Patents

Oral sustained release formulation of tedisamil with gastric retention properties

Info

Publication number
TW200603793A
TW200603793A TW094121159A TW94121159A TW200603793A TW 200603793 A TW200603793 A TW 200603793A TW 094121159 A TW094121159 A TW 094121159A TW 94121159 A TW94121159 A TW 94121159A TW 200603793 A TW200603793 A TW 200603793A
Authority
TW
Taiwan
Prior art keywords
tedisamil
sustained release
release formulation
retention properties
gastric retention
Prior art date
Application number
TW094121159A
Other languages
English (en)
Chinese (zh)
Inventor
Santa Fabiano
Johan A Bakker
Marius L De Winter
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of TW200603793A publication Critical patent/TW200603793A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TW094121159A 2004-06-28 2005-06-24 Oral sustained release formulation of tedisamil with gastric retention properties TW200603793A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04102987 2004-06-28

Publications (1)

Publication Number Publication Date
TW200603793A true TW200603793A (en) 2006-02-01

Family

ID=34929254

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094121159A TW200603793A (en) 2004-06-28 2005-06-24 Oral sustained release formulation of tedisamil with gastric retention properties

Country Status (5)

Country Link
CN (1) CN1976683B (es)
AR (1) AR049936A1 (es)
BR (1) BRPI0512671A (es)
TW (1) TW200603793A (es)
UA (1) UA86629C2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109602714B (zh) * 2018-12-29 2020-06-12 广东中润药物研发有限公司 一种利伐沙班胃滞留片及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03002769A (es) * 2000-09-29 2003-07-28 Solvay Pharm Bv Formulacion farmaceutica de liberacion sostenida e independiente de la densidad ionica.

Also Published As

Publication number Publication date
CN1976683B (zh) 2010-10-06
AR049936A1 (es) 2006-09-13
BRPI0512671A (pt) 2008-04-01
CN1976683A (zh) 2007-06-06
UA86629C2 (ru) 2009-05-12

Similar Documents

Publication Publication Date Title
IL179859A0 (en) Oral sustained release formulation of tedisamil with gastric retention properties
WO2006067165A3 (en) Indolidone derivatives for the treatment or prevention of fibrotic diseases
WO2004030611A3 (en) Non-nucleoside reverse transcriptase inhibitors
WO2009017837A3 (en) Sublingual fentanyl spray
IL186555A (en) (4r, 9as) –5– Hydroxy – 4 – methyl – 6,10 – dioxo –10.9 a, 9,6,4,3 – hexahydro – 2 h – 1– oxa –8 a, 4a 4,2-diplooro-benzylamide carboxylic acid or its pharmacy salt, a preparation containing it and its use in the treatment or prevention of HIV
CA3094580C (en) Oral formulations of cytidine analogs and methods of use thereof
WO2007087431A3 (en) Sublingual fentanyl spray
NO20080088L (no) Sterkt biotilgjengelige orale forsinkede frigjoringsformer av O-desmetylvenlafaksin
WO2010016683A3 (ko) 탈모의 예방, 치료, 또는 육모용 조성물
WO2007038112A3 (en) Combination of rosiglitazone and donepezil for improvement of cognitive function
NZ605469A (en) Nalbuphine-based formulations and uses thereof
TW200637544A (en) Medicaments for the treatment or prevention of fibrotic diseases
TW200635595A (en) Medicaments for the treatment of prevention of fibrotic diseases
WO2005082413A3 (en) Ciclesonide and glycopyrronium combination
EP2384746A3 (en) Dual release oral tablet compositions of dexlansoprazole
EP2392337A3 (en) Use of 24-norUDCA
WO2007130509A3 (en) Pyrroloquinoline quinones and use thereof
EA200702201A1 (ru) Рофлумиласт для лечения лёгочной гипертензии
WO2006079910A3 (en) 0-(3-piperidino-2hydroxypropyl)nicotinic amixodime for treating lesions in the oral cavity
TW200603793A (en) Oral sustained release formulation of tedisamil with gastric retention properties
TW200640446A (en) Prophylactic anti-stress agent
WO2005107871A3 (en) Pyrroloquinoline quinone drugs for treatment of cardiac injury
EA200801890A1 (ru) Средство для лечения шума в ушах
SI1747201T1 (sl) Derivati 2H- ali 3-H-benzo (e)indazol-1-il karbamata, njihova priprava in njihova terapevtska uporaba
ATE525064T1 (de) Pharmazeutische zusammensetzung mit desloratadin